Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial JR Teerlink, G Cotter, BA Davison, GM Felker, G Filippatos, ... The Lancet 381 (9860), 29-39, 2013 | 1038 | 2013 |
Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema G Cotter, E Metzkor, E Kaluski, Z Faigenberg, R Miller, A Simovitz, ... The Lancet 351 (9100), 389-393, 1998 | 770 | 1998 |
Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure BM Massie, CM O'Connor, M Metra, P Ponikowski, JR Teerlink, G Cotter, ... New England Journal of Medicine 363 (15), 1419-1428, 2010 | 589 | 2010 |
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes M Metra, G Cotter, BA Davison, GM Felker, G Filippatos, BH Greenberg, ... Journal of the American College of Cardiology 61 (2), 196-206, 2013 | 513 | 2013 |
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials JJV McMurray, JR Teerlink, G Cotter, RC Bourge, JGF Cleland, ... Jama 298 (17), 2009-2019, 2007 | 397 | 2007 |
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial A Mebazaa, B Davison, O Chioncel, A Cohen-Solal, R Diaz, G Filippatos, ... The Lancet 400 (10367), 1938-1952, 2022 | 392 | 2022 |
Fluid overload in acute heart failure—re‐distribution and other mechanisms beyond fluid accumulation G Cotter, M Metra, O Milo‐Cotter, HC Dittrich, M Gheorghiade European journal of heart failure 10 (2), 165-169, 2008 | 361 | 2008 |
The role of the kidney in heart failure M Metra, G Cotter, M Gheorghiade, L Dei Cas, AA Voors European heart journal 33 (17), 2135-2142, 2012 | 347 | 2012 |
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials BA Davison, SA Harrison, G Cotter, N Alkhouri, A Sanyal, C Edwards, ... Journal of hepatology 73 (6), 1322-1332, 2020 | 312 | 2020 |
High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema A Sharon, I Shpirer, E Kaluski, Y Moshkovitz, O Milovanov, R Polak, ... Journal of the American College of Cardiology 36 (3), 832-837, 2000 | 309 | 2000 |
Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction E Shemesh, R Yehuda, O Milo, I Dinur, A Rudnick, Z Vered, G Cotter Psychosomatic medicine 66 (4), 521-526, 2004 | 285 | 2004 |
Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? G Cotter, E Shemesh, M Zehavi, I Dinur, A Rudnick, O Milo, Z Vered, ... American heart journal 147 (2), 293-300, 2004 | 285 | 2004 |
Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome PC Colombo, A Ganda, J Lin, D Onat, A Harxhi, JE Iyasere, N Uriel, ... Heart failure reviews 17, 177-190, 2012 | 241 | 2012 |
The pathophysiology of acute heart failure—is it all about fluid accumulation? G Cotter, GM Felker, KF Adams, O Milo-Cotter, CM O'Connor American heart journal 155 (1), 9-18, 2008 | 230 | 2008 |
Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial J Bartunek, A Terzic, BA Davison, GS Filippatos, S Radovanovic, ... European heart journal 38 (9), 648-660, 2017 | 226 | 2017 |
Effects of serelaxin in patients with acute heart failure M Metra, JR Teerlink, G Cotter, BA Davison, GM Felker, G Filippatos, ... New England Journal of Medicine 381 (8), 716-726, 2019 | 221 | 2019 |
Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure J Rubio-Gracia, BG Demissei, JM Ter Maaten, JG Cleland, CM O'Connor, ... International journal of cardiology 258, 185-191, 2018 | 217 | 2018 |
Role of cardiac power in heart failure G Cotter, SG Williams, Z Vered, LB Tan Current opinion in cardiology 18 (3), 215-222, 2003 | 217 | 2003 |
The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure G Cotter, Y Moshkovitz, E Kaluski, O Milo, Y Nobikov, A Schneeweiss, ... European journal of heart failure 5 (4), 443-451, 2003 | 216 | 2003 |
Signature of circulating microRNAs in patients with acute heart failure ES Ovchinnikova, D Schmitter, EL Vegter, JM Ter Maaten, MAE Valente, ... European journal of heart failure 18 (4), 414-423, 2016 | 211 | 2016 |